Pacira BioSciences Presents Two Real-World Studies from Its Innovations in Genicular Outcomes Registry (IGOR)

Studies highlight the clinical effectiveness of EXPAREL for total knee arthroplasty and long-term pain management with ioveraº for patients ...
Benzinga.com

Pacira BioSciences Secures FDA Approval For New iovera SmartTip to Manage Chronic Low Back Pain

On Tuesday, Pacira BioSciences, Inc. (NASDAQ:PCRX) received FDA clearance to market a new Smart Tip designed to access the medial branch nerves to manage chronic low back pain. The ioveraº system is a ...
Las Vegas Weekly

iovera°: An Immediate Non-Drug Solution for Osteoarthritis Pain

In 2021, it was estimated that about 23% of adults living in Las Vegas, NV had arthritis. Osteoarthritis (OA), the most common form of arthritis, affects millions of people worldwide. OA symptoms can ...
Business Wire

Myoscience Announces Data Demonstrating iovera Therapy is an Effective Alternative to Opioids for Pain Relief Following Knee Replacement Surgery

FREMONT, Calif. & LAS VEGAS--(BUSINESS WIRE)--Myoscience, Inc., a medical device company dedicated to relieving pain through targeted therapies, today announced clinical trial results demonstrating ...
KHON2

New Tech: Opioid-free pain management with iovera°

Dr. Paul Norio Morton is a local, Big Island boy and Orthopedic Surgeon known for his specialty in robotic-assisted knee and hip replacement surgery, earning him the nickname “The Robot Doc.” As usual ...
Nasdaq

PCRX's Iovera Outperforms RFA Therapy in Pilot Study for Low Back Pain

Pacira BioSciences PCRX announced results from a pilot study evaluating the unique therapeutic approach of its iovera system compared to radiofrequency ablation (RFA) for chronic low back pain (CLBP).